Have any questions?
+44 1234 567 890
i2medi and ABEC are submitting a request for reimbursement to the Brazilian Health Insurance Association.
In collaboration with professional associations, i2medi was able to secure the inclusion of CCM therapy in the guidelines of the Brazilian SOBRAC.
Claudio Costa—Sales Director and Technical Director of i2medi Brazil—explained that the second step has now been taken
“To enable patients and the medical community to access this new therapy, CCM therapy must be included in Brazil’s list of approved medical treatments. i2medi prepared the corresponding health economic assessment in close collaboration with leading experts in Brazil.
The professional association ABEC is supporting the application with the Central Association of Private Health Insurers in Brazil.